NCT02947048View on ClinicalTrials.gov

Safety of L1-79 in Adolescent and Adult Males With Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

February 1, 2018

Conditions
Autism
Interventions
DRUG

L1-79

DRUG

Placebo

Trial Locations (2)

07039

Eric Bartky MD, Bartky Health Care Center, Livingston

07850

F. Peter Halas MD, Sea Girt Pediatrics, Sea Girt

All Listed Sponsors
lead

Yamo Pharmaceuticals LLC

INDUSTRY

NCT02947048 - Safety of L1-79 in Adolescent and Adult Males With Autism | Biotech Hunter | Biotech Hunter